Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets - PubMed (original) (raw)
. 2004 Nov 1;190(9):1627-30.
doi: 10.1086/424572. Epub 2004 Sep 28.
Affiliations
- PMID: 15478068
- DOI: 10.1086/424572
Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets
M Louise Herlocher et al. J Infect Dis. 2004.
Abstract
Three type A influenza viruses, each of which has a distinct neuraminidase-gene mutation and is resistant to the neuraminidase inhibitor oseltamivir, have been isolated. Previously, in the ferret model, an R292K mutant of a type A (H3N2) virus was not transmitted under conditions in which the wild-type virus was transmitted. This model was used to investigate whether the E119V mutant of a type A (H3N2) virus and the H274Y mutant of a type A (H1N1) virus would be transmitted under similar circumstances. Both mutant viruses were transmitted, although the H274Y mutant required a 100-fold-higher dose for infection of donor ferrets and was transmitted more slowly than was the wild type. Both the mutant and the wild-type viruses retained their genotypic characteristics.
Similar articles
- Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Hurt AC, Lowther S, Middleton D, Barr IG. Hurt AC, et al. Antiviral Res. 2010 Sep;87(3):361-6. doi: 10.1016/j.antiviral.2010.06.009. Epub 2010 Jul 21. Antiviral Res. 2010. PMID: 20603155 - Reduced airborne transmission of oseltamivir-resistant pandemic A/H1N1 virus in ferrets.
Hamelin ME, Baz M, Bouhy X, Beaulieu E, Dubé K, Mallett C, Boivin G. Hamelin ME, et al. Antivir Ther. 2011;16(5):775-9. doi: 10.3851/IMP1794. Antivir Ther. 2011. PMID: 21817200 - Influenza virus susceptibility and resistance to oseltamivir.
Aoki FY, Boivin G, Roberts N. Aoki FY, et al. Antivir Ther. 2007;12(4 Pt B):603-16. Antivir Ther. 2007. PMID: 17944268 Review. - Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
Ferraris O, Lina B. Ferraris O, et al. J Clin Virol. 2008 Jan;41(1):13-9. doi: 10.1016/j.jcv.2007.10.020. Epub 2007 Dec 11. J Clin Virol. 2008. PMID: 18055254 Review.
Cited by
- In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir.
Kiso M, Furusawa Y, Uraki R, Imai M, Yamayoshi S, Kawaoka Y. Kiso M, et al. Nat Commun. 2023 Jul 4;14(1):3952. doi: 10.1038/s41467-023-39704-x. Nat Commun. 2023. PMID: 37402789 Free PMC article. - Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors.
Kiso M, Yamayoshi S, Kawaoka Y. Kiso M, et al. J Antimicrob Chemother. 2023 Jul 5;78(7):1649-1657. doi: 10.1093/jac/dkad145. J Antimicrob Chemother. 2023. PMID: 37209424 Free PMC article. - Theoretical and numerical results of a stochastic model describing resistance and non-resistance strains of influenza.
Farah EM, Amine S, Ahmad S, Nonlaopon K, Allali K. Farah EM, et al. Eur Phys J Plus. 2022;137(10):1169. doi: 10.1140/epjp/s13360-022-03302-5. Epub 2022 Oct 21. Eur Phys J Plus. 2022. PMID: 36310610 Free PMC article. - Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
Farrukee R, Gunalan V, Maurer-Stroh S, Reading PC, Hurt AC. Farrukee R, et al. J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14. J Virol. 2022. PMID: 35867563 Free PMC article. - Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
Jiang L, Samant N, Liu P, Somasundaran M, Jensen JD, Marasco WA, Kowalik TF, Schiffer CA, Finberg RW, Wang JP, Bolon DNA. Jiang L, et al. J Virol. 2022 Mar 23;96(6):e0198221. doi: 10.1128/jvi.01982-21. Epub 2022 Jan 19. J Virol. 2022. PMID: 35045267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources